Dumb to move from PE at FO > RX IB?

I never did banking, went from corp M&A to PE at a FO. Currently a Sr ASO. Been interested in RX since college but wasn't really competitive for recruiting at any of the T1/2 banks (sub 3.5 GPA, non-target). Given the current climate it seems like a good place to be and it's been tough to lateral to a true PE fund so I'm back to thinking about it. Now that I've got 5+ years of FTE would it be a dumb move to try? Would I even be a competitive candidate in my late-20s? 

4 Comments
 

Transitioning from PE at a Family Office (FO) to RX IB isn't necessarily a "dumb" move, but it depends on your long-term goals and how you position yourself. Based on the most helpful WSO content, here are some key considerations:

  1. Interest in RX: If you've been genuinely interested in restructuring since college, this could be a great opportunity to align your career with your passions. RX can be a fascinating field, especially in the current economic climate, where distressed opportunities are more prevalent.

  2. Competitiveness: With 5+ years of experience, you may face challenges breaking into RX IB, especially at top-tier banks. However, your PE and corporate M&A background could be valuable if you can demonstrate strong financial acumen, deal execution skills, and an understanding of distressed situations. Late 20s isn't a dealbreaker, but you'll need to show you're committed to the transition.

  3. Market Climate: The current climate does favor RX, as downturns often lead to increased deal flow in this space. This could make it a strategic move, especially if you're struggling to lateral to a traditional PE fund.

  4. Challenges in RX: Keep in mind that RX is often pitch-heavy, with fewer repeat clients compared to M&A. Promotion paths to MD can also be more challenging due to the limited number of RX deals, as highlighted in WSO discussions.

  5. Exit Opportunities: RX can open doors to distressed-focused PE funds or other specialized roles, but it may narrow your options for generalist PE roles in the future. If your ultimate goal is to return to PE, consider whether RX aligns with that trajectory.

In summary, it's not a "dumb" move if RX aligns with your interests and you can leverage your existing experience effectively. However, be prepared for the challenges of breaking into the field and consider how it fits into your long-term career goals.

Sources: Pros & Cons Summary - Post-MBAs in Restructuring (RX) - any regrets?, Choosing RX over M&A -- anyone recommend this?, Can I transition from restructuring to regular private equity?, Bain Capital PE vs PJT RSSG, Moving from Asset Management into IB / PE

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Comp is meh (as it is for most FOs) and work has gotten boring. I think RX has a strong tailwind to ride and have been interested in distressed/special sits roles but don't have the background for it/can't competitively lateral from my current seat so it seems like getting banking on the resume for a couple of years could solve that problem.

 

Nihil suscipit molestias quos quia aut. Labore animi eum repudiandae culpa neque ducimus. Pariatur exercitationem eum quae fuga explicabo aut. Consectetur voluptatem enim laboriosam at ab. Dolorum voluptatem ut adipisci a ipsum.

Et placeat fugit modi libero. Voluptates laboriosam nulla fuga blanditiis ratione. Dicta alias sequi dolor quibusdam quidem et. Dolores tenetur delectus autem aliquid veniam aspernatur expedita. Cumque dignissimos in autem provident et.

Nesciunt id in est recusandae deleniti. Velit facere mollitia ut sed eos laboriosam eum rerum. Odio alias nemo odit ex eaque reprehenderit saepe. Beatae voluptates quis quis vel voluptatibus voluptas pariatur. Deserunt quis ad maxime provident nisi. Ratione itaque sint ratione pariatur eos.

Career Advancement Opportunities

June 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.2%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Bain Capital 98.1%

Overall Employee Satisfaction

June 2026 Private Equity

  • KKR (Kohlberg Kravis Roberts) 99.6%
  • The Riverside Company 99.2%
  • Blackstone Group 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

June 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.2%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

June 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (97) $363
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (95) $134
  • 1st Year Analyst (271) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (353) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”